Improving Transplant Recipient Outcomes
Eurofins Transplant Genomics is committed to improving organ transplant outcomes with noninvasive diagnostics guided by genetic biomarkers.
Our Molecular Diagnostic Tests
Eurofins Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.
Biomarker Science
Kidney
For kidney transplantation, doctors assess blood type compatibility and tissue matches. They perform tests to check for underlying health issues that might affect the success of the transplant. Since people with two healthy kidneys can live with one, living donors can be considered in addition to deceased donors. Doctors evaluate living donors’ health and compatibility during the pre-transplant process.
Liver
For liver transplantation, doctors study a patient’s liver disease severity, overall health, and potential for complications. They conduct blood tests, imaging scans, and assessments of liver function. The patient’s position on the waiting list is determined by a scoring system, which considers factors like urgency and severity. Like kidney transplants, liver transplants can be performed with organs from living donors.
How Can We Help
Surveillance for Subclinical Acute Rejection
Resources
Pay your balance online.
If you have received a billing statement from Transplant Genomics, you can pay your balance quickly and securely through our online patient portal. Have your billing statement ready — you will need your date of birth, Accession ID number, and ZIP code from your statement to log in.
Pay My Bill →
to open the portal